Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : NZ-TLR9
Therapeutic Area : Oncology
Study Phase : Preclinical
Sponsor : Lidds
Deal Size : Undisclosed
Deal Type : Collaboration
Lidds and Pharmidea Signs Manufacturing Agreement
Details : The collaboration enables LIDDS to expand the manufacturing of new product candidates, e.g. including biomolecules and cytostatics, in addition to the already existing collaboration with Recipharm for Liproca Depot.
Brand Name : NZ-TLR9
Molecule Type : Undisclosed
Upfront Cash : Undisclosed
February 26, 2021
Lead Product(s) : NZ-TLR9
Therapeutic Area : Oncology
Highest Development Status : Preclinical
Sponsor : Lidds
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?